Feasibility and safety of extensive upper abdominal surgery in elderly patients with advanced epithelial ovarian cancer

Journal of Korean Medical Science

Volumn 25, Issue 7, 2010, Pages 1034-1040

  Lim, Myong Cheol ^a   Kang, Sokbom ^a   Song, Yong Jung ^a,b   Park, Sae Hyun ^a   Park, Sang Yoon ^a  

^a National Cancer Center   (South Korea)

^b Pusan National University Yangsan Hospital   (South Korea)

Author keywords

Aged; Complications; Extensive upper abdominal Surgery; Ovarian neoplasms; Risk factors; Surgery

Indexed keywords

ABDOMEN; ADULT; AGE; AGED; ARTICLE; DISEASE FREE SURVIVAL; FEMALE; GYNECOLOGIC SURGERY; HUMAN; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; OVARY TUMOR; PATHOLOGY; RETROSPECTIVE STUDY; TREATMENT OUTCOME; OVARIAN NEOPLASMS;

ABDOMEN; ADULT; AGE FACTORS; AGED; DISEASE-FREE SURVIVAL; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; KAPLAN-MEIERS ESTIMATE; MIDDLE AGED; OVARIAN NEOPLASMS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; KAPLAN-MEIER ESTIMATE;

EID: 77956533065     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2010.25.7.1034     Document Type: Article

References (28)

1. Choi M, Fuller CD, Thomas CR Jr, Wang SJ. Conditional survival in ovarian cancer: results from the SEER dataset 1988-2001. Gynecol Oncol 2008; 109: 203-9.
2. Yancik R, Ries LG, Yates JW. Ovarian cancer in the elderly: an analysis of Surveillance, Epidemiology, and End Results Program data. Am J Obstet Gynecol 1986; 154: 639-47.
3. Chung HH, Hwang SY, Jung KW, Won YJ, Shin HR, Kim JW, Lee HP. Ovarian cancer incidence and survival in Korea: 1993-2002. Int J Gynecol Cancer 2007; 17: 595-600.
4. Cloven NG, Manetta A, Berman ML, Kohler MF, DiSaia PJ. Management of ovarian cancer in patients older than 80 years of age. Gynecol Oncol 1999; 73: 137-9.
5. Bruchim I, Altaras M, Fishman A. Age contrasts in clinical characteristics and pattern of care in patients with epithelial ovarian cancer. Gynecol Oncol 2002; 86: 274-8.
6. Edmonson JH, Su J, Krook JE. Treatment of ovarian cancer in elderly women. Mayo Clinic-North Central Cancer Treatment Group studies. Cancer 1993; 71: 615-7.
7. Gershenson DM, Mitchell MF, Atkinson N, Silva EG, Burke TW, Morris M, Kavanagh JJ, Warner D, Wharton JT. Age contrasts in patients with advanced epithelial ovarian cancer. The M.D. Anderson Cancer Center experience. Cancer 1993; 71: 638-43.
8. Markman M, Lewis JL Jr, Saigo P, Hakes T, Jones W, Rubin S, Reichman B, Barakat R, Curtin J, Almadrones L. Epithelial ovarian cancer in the elderly. The Memorial Sloan-Kettering Cancer Center experience. Cancer 1993; 71: 634-7.
9. Pignata S, Vermorken JB. Ovarian cancer in the elderly. Crit Rev Oncol Hematol 2004; 49: 77-86.
10. Wright JD, Herzog TJ, Powell MA. Morbidity of cytoreductive surgery in the elderly. Am J Obstet Gynecol 2004; 190: 1398-400.
11. Alphs HH, Zahurak ML, Bristow RE, Diaz-Montes TP. Predictors of surgical outcome and survival among elderly women diagnosed with ovarian and primary peritoneal cancer. Gynecol Oncol 2006; 103: 1048-53.
12. Sharma S, Driscoll D, Odunsi K, Venkatadri A, Lele S. Safety and efficacy of cytoreductive surgery for epithelial ovarian cancer in elderly and high-risk surgical patients. Am J Obstet Gynecol 2005; 193: 2077-82.
13. Susini T, Amunni G, Busi E, Villanucci A, Carriero C, Taddei G, Marchionni M, Scarselli G. Ovarian cancer in the elderly: feasibility of surgery and chemotherapy in 89 geriatric patients. Int J Gynecol Cancer 2007; 17: 581-8.
14. Uyar D, Frasure HE, Markman M, von Gruenigen VE. Treatment patterns by decade of life in elderly women (> or =70 years of age) with ovarian cancer. Gynecol Oncol 2005; 98: 403-8.
15. Eisenkop SM, Friedman RL, Wang HJ. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study. Gynecol Oncol 1998; 69: 103-8.
16. Eisenkop SM, Spirtos NM, Friedman RL, Lin WC, Pisani AL, Perticucci S. Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study. Gynecol Oncol 2003; 90: 390-6.
17. Chi DS, Franklin CC, Levine DA, Akselrod F, Sabbatini P, Jarnagin WR, DeMatteo R, Poynor EA, Abu-Rustum NR, Barakat RR. Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach. Gynecol Oncol 2004; 94: 650-4.
18. Eisenhauer EL, Abu-Rustum NR, Sonoda Y, Levine DA, Poynor EA, Aghajanian C, Jarnagin WR, DeMatteo RP, D'Angelica MI, Barakat RR, Chi DS. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer. Gynecol Oncol 2006; 103: 1083-90.
19. Zivanovic O, Eisenhauer EL, Zhou Q, Iasonos A, Sabbatini P, Sonoda Y, Abu-Rustum NR, Barakat RR, Chi DS. The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer. Gynecol Oncol 2008; 108: 287-92.
20. Lee JH, Kim KS, Chung CW, Park YN, Kim BR. Hepatic resection of metastatic tumor from serous cystadenocarcinoma of the ovary. J Korean Med Sci 2002; 17: 415-8.
21. Bae J, Lim MC, Choi JH, Song YJ, Lee KS, Kang S, Seo SS, Park SY. Prognostic factors of secondary cytoreductive surgery for patients with recurrent epithelial ovarian cancer. J Gynecol Oncol 2009; 20: 101-6.
22. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-83.
23. Lim MC, Kang S, Lee KS, Han SS, Park SJ, Seo SS, Park SY. The clinical significance of hepatic parenchymal metastasis in patients with primary epithelial ovarian cancer. Gynecol Oncol 2009; 112: 28-34.
24. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 2002; 20: 1248-59.
25. Cliby W, Dowdy S, Feitoza SS, Gostout BS, Podratz KC. Diaphragm resection for ovarian cancer: technique and short-term complications. Gynecol Oncol 2004; 94: 655-60.
26. Eisenhauer EL, D'Angelica MI, Abu-Rustum NR, Sonoda Y, Jarnagin WR, Barakat RR, Chi DS. Incidence and management of pleural effusions after diaphragm peritonectomy or resection for advanced mullerian can cer. Gynecol Oncol 2006; 103: 871-7.
27. Dowdy SC, Loewen RT, Aletti G, Feitoza SS, Cliby W. Assessment of outcomes and morbidity following diaphragmatic peritonectomy for women with ovarian carcinoma. Gynecol Oncol 2008; 109: 303-7.
28. Janda M, Youlden DR, Baade PD, Jackson D, Obermair A. Elderly patients with stage III or IV ovarian cancer: should they receive standard care? Int J Gynecol Cancer 2008; 18: 896-907.